
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters. In Q4, Globus Medical brought in $250.02 million in sales but only earned $15.11 million.